In this weeks exclusive, members-only HHCN+ Update, I discuss theoretical and concrete reductions to Medicaid funding to discover the likely scenarios for the future of Medicaid under the current administration, and I offer analysis and key takeaways, including: What the available evidence says about the Trump administrations approach to Medicaid The potential impact of Medicaid cuts on home-based care providers My conclusions about what the home care community can predict The body of evidence The Trump administration has insisted that it wont cut Medicaid benefits, as stated in a post on the official White House website
Recovery that keeps up
Benefits AOD-9604 is believed to help with: Mechanistically designed to support fat breakdown and reduce new fat formation while having minimal direct impact on blood sugar and IGF1. May offer modest additional help with fat metabolism when combined with calorie control and exercise, particularly in higheradiposity individuals. Typically administered as a daily subcutaneous injection in low doses, integrated into a broader metabolic and lifestyle protocol. Longterm clinical safety data show generally good tolerability in studied populations, but regulators have highlighted unresolved immunogenicity and impurity concerns, so usage must remain cautious and fully consented. Positioned as an optional, supportive layernot a standalone weight-loss solutionwith emphasis on lab monitoring, habit coaching, and realistic expectations.

UCB reported in October 2021 that the FDA had to delay its verdict on the drugs Biologics License Application because it was unable to conduct on-site facility inspections due to travel restrictions
No peptide on this list has a published, pre-registered, placebo-controlled human RCT in healthy adults demonstrating robust cognitive improvement
When starting semaglutide for weight loss, most people experience significant appetite suppression, which helps them eat fewer calories and make healthier food choices